Congratulations !!

Evaluating synergistic versus additive effects of the triplet regimen in metastatic castration-sensitive prostate cancer: a modeling analysis.

Hata S, Suzuki S, Fujinami H, Yamanaka N, Shin T.

Jpn J Clin Oncol.2025 Dec 31:hyaf211. doi: 10.1093/jjco/hyaf211.

Prognostic impact of concomitant carcinoma in situ in patients undergoing BCG therapy or radical cystectomy for bladder cancer.

Hata S, Abe S, Todaka M, Suzuki S, Fujinami H, Yamanaka N, Shinohara M, Shin T.

Japanese Journal of Endourology and Robotics.2025; 38: 269-273.